Amyloidosis relapsing after autologous stem cell transplantation treated with bortezomib: normalization of detectable serum-free light chains and reversal of tissue damage with imp...

Por Brunvand, Mark W., Bitter, Mitchell
Publicado em 2010

Complete remission with romidepsin in a patient with T‐cell acute lymphoblastic leukemia refractory to induction hyper‐CVAD

Por Brunvand, Mark W., Carson, John
Publicado no Hematol Oncol (2017)

A phase I study of PRO131921, a novel anti-CD20 monoclonal antibody in patients with relapsed/refractory CD20 + indolent NHL: Correlation between clinical responses and AUC pharmac...

Por Casulo, Carla, Vose, Julie M., Ho, William Y., Kahl, Brad, Brunvand, Mark, Goy, Andre, Kasamon, Yvette, Cheson, Bruce, Friedberg, Jonathan W.
Publicado no Clin Immunol (2014)

Phase I Study of the Anti-CD22 Antibody–Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Por Advani, Ranjana H., Lebovic, Daniel, Chen, Andy, Brunvand, Mark, Goy, Andre, Chang, Julie E., Hochberg, Ephraim, Yalamanchili, Sreeni, Kahn, Robert, Lu, Dan, Agarwal, Priya, Dere, Randall C., Hsieh, Hsin-Ju, Jones, Surai, Chu, Yu-Waye, Cheson, Bruce D.
Publicado no Clin Cancer Res (2016)